CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Active    As on: 05 June, 2023    Update Info    Print    Share

OVERVIEW - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Centrient Pharmaceuticals India Private Limited is an unlisted private company incorporated on 19 January, 1993. It is classified as a private limited company and is located in Toansa, Punjab. It's authorized share capital is INR 170.00 cr and the total paid-up capital is INR 160.30 cr.

Centrient Pharmaceuticals India's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by -10.15 % over the previous year. At the same time, it's book networth has increased by 14.85 %. Other performance and liquidity ratios are available here.

Description: The company manufactures anti-infective active pharmaceutical ingredients (mainly semi-synthetic penicillin and statins) at its plant.

Products & Services: Beta-lactam antibiotics, generic intermediates, active pharmaceutical ingredients, and other drug products.
Category: Manufacturer

The current status of Centrient Pharmaceuticals India Private Limited is - Active.

The last reported AGM (Annual General Meeting) of Centrient Pharmaceuticals India Private Limited, per our records, was held on 14 September, 2022.

Centrient Pharmaceuticals India Private Limited has three directors - Namit Joshi, Devesh Prakash Srivastava, and others.

The Corporate Identification Number (CIN) of Centrient Pharmaceuticals India Private Limited is U24231PB1993PTC023090. The registered office of Centrient Pharmaceuticals India Private Limited is at Bhai Mohan Singh Nagar, , Toansa, Punjab.

The Modern SME TOFLER
Uncovering inspirational lessons from success of "Sony"

Watch this video to see how "Sony" and its founder "Akio Morita" started from a bombed-out store and became one of the most influential companies in the world! You will see how they faced obstacles, created innovations, & established a global reputation that shaped the future. This is a must-watch video if you want to be inspired & empowered by a true leader!

Watch full video
  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2022. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest newsletters:

How Walmart Became the World’s Largest Retailer:  Learn from the Sales and Marketing Strategies of Walmart

Faasos: Embark on a Flavorful Culinary Journey

REGISTERED DETAILS - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED


CIN

U24231PB1993PTC023090

Incorporation Date / Age

19 January, 1993 / 30 yrs

Last Reported AGM Date

14 September, 2022

Authorized Capital

INR 17000.0 Lacs

Paidup Capital

INR 16030.0696 Lacs

industry*

Manufacturing (Chemicals and chemical products)

type

Unlisted Private Company

category

Company limited by Shares

subcategory

Non-govt company

Email Address

Login for email address. This is to prevent spam.

Website

Website not known. Click here to let us know.

Registered Address

Bhai Mohan Singh Nagar

Toansa - 144533
Punjab - India

How to download CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED - Registration Details
CINU24231PB1993PTC023090
Incorporation Date / Age19 January, 1993 / 30 yrs
Last Reported AGM Date14 September, 2022
Authorized CapitalINR 17000.0 Lacs
Paidup CapitalINR 16030.0696 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeUnlisted Private Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Website
Registered AddressBhai Mohan Singh Nagar  Toansa - 144533 Punjab - India

FINANCIAL HIGHLIGHTS - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2022. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue Over INR 500 cr
EBITDA -10.15 %
Networth 14.85 %
Debt/Equity Ratio 0.12
Return on Equity 12.84 %
See more...

* Company has reported to have approved financials for 31 March, 2022. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
How to get financial reports of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

The company has 3 directors and 2 reported key management personnel.


The longest serving director currently on board is Namit Joshi who was appointed on 29 July, 2021. Namit Joshi has been on the board for 1 years and 10 months. The most recently appointed director is Devesh Prakash Srivastava, who was appointed on 01 April, 2023.


Devesh Prakash Srivastava has the largest number of other directorships with a seat at a total of 2 companies. In total, the company is connected to 1 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
NAMIT JOSHI Director 29 July, 2021 No other directorships
DEVESH PRAKASH SRIVASTAVA Director 01 April, 2023 Other directorships - ASTRAL STERITECH PRIVATE LIMITED, 
VIKRAM ADITYA SEHGAL KMP 04 June, 2021 No other directorships
VIKRAM ADITYA SEHGAL Director 30 September, 2021 Other directorships - ASTRAL STERITECH PRIVATE LIMITED, 
SUMIT AGARWAL KMP 17 December, 2020 No other directorships
NAME DESIGNATION APPOINTMENT DATE
NAMIT JOSHI Director 29 July, 2021 No other directorships
DEVESH PRAKASH SRIVASTAVA Director 01 April, 2023 View other directorships
VIKRAM ADITYA SEHGAL KMP 04 June, 2021 No other directorships
VIKRAM ADITYA SEHGAL Director 30 September, 2021 View other directorships
SUMIT AGARWAL KMP 17 December, 2020 No other directorships
17 December, 2020

SUMIT AGARWAL

KMP

04 June, 2021

VIKRAM ADITYA SEHGAL

KMP

29 July, 2021

NAMIT JOSHI

Director

30 September, 2021

VIKRAM ADITYA SEHGAL

Director

01 April, 2023

DEVESH PRAKASH SRIVASTAVA

Director

Bank-wise Biggest Charges on Assets

See more...

Previous Names

DSM ANTI INFECTIVES INDIA LIMITED
DSM SINOCHEM PHARMACEUTICALS INDIA LIMITED
DSM SINOCHEM PHARMACEUTICALS INDIA PRIVATE LIMITED
MAX-GB (P) LIMITED

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
CIPLA LIMITED It was formed in year 1935 in Maharashtra . The company currently has a paid up capital of INR 161.43 cr.
1935 Maharashtra 161.43 cr Buy financial reports
FRESENIUS MEDICAL CARE INDIA PRIVATE LIMITED It was formed in year 2006 in Delhi . The company currently has a paid up capital of INR 159.12 cr.
2006 Delhi 159.12 cr Buy financial reports
ARCH PHARMALABS LIMITED It was formed in year 1993 in Maharashtra . The company currently has a paid up capital of INR 156.48 cr.
1993 Maharashtra 156.48 cr Buy financial reports
UPL LIMITED It was formed in year 1985 in Gujarat . The company currently has a paid up capital of INR 152.81 cr.
1985 Gujarat 152.81 cr Buy financial reports
TORRENT PHARMACEUTICALS LTD It was formed in year 1972 in Gujarat . The company currently has a paid up capital of INR 169.22 cr.
1972 Gujarat 169.22 cr Buy financial reports
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED It was formed in year 1924 in Maharashtra . The company currently has a paid up capital of INR 169.41 cr.
1924 Maharashtra 169.41 cr Buy financial reports
HETERO BIOPHARMA LIMITED It was formed in year 2016 in Telangana . The company currently has a paid up capital of INR 150.05 cr.
2016 Telangana 150.05 cr Buy financial reports
NISSAN BHARAT RASAYAN PRIVATE LIMITED It was formed in year 2019 in Haryana . The company currently has a paid up capital of INR 150.00 cr.
2019 Haryana 150.00 cr Buy financial reports
ADD-LIFE PHARMA LTD It was formed in year 1991 in Gujarat . The company currently has a paid up capital of INR 149.76 cr.
1991 Gujarat 149.76 cr Buy financial reports
JIVAGRO LIMITED It was formed in year 2019 in Maharashtra . The company currently has a paid up capital of INR 148.83 cr.
2019 Maharashtra 148.83 cr Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Company Network • Tofler Business Research Platform
How to use company network of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

About - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED Edit

Add Company Info • Tofler Business Research Platform

FAQ - CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED

  • What is the Incorporation date of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED?

    The Incorporation Date of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED is 19 January, 1993.

  • What is the operating revenue of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED?

    The operating revenue of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED is in the range of Over INR 500 cr for the financial year ending on 31 March, 2022.

  • What is the change in EBITDA of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED since last year?

    The EBITDA of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED has decreased by -10.15 % over the previous year. At the same time, it's book networth has increased by 14.85 % for the financial year ending 31 March, 2022.

  • What is the business of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED?

    The company manufactures anti-infective active pharmaceutical ingredients (mainly semi-synthetic penicillin and statins) at its plant..

  • Which Products and Services are provided by CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED?

    The products and services offered by CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED are Beta-lactam antibiotics, generic intermediates, active pharmaceutical ingredients, and other drug products..

  • Who are the directors of CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED?

    Centrient Pharmaceuticals India Private Limited has three directors - Namit Joshi, Devesh Prakash Srivastava, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2022. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest newsletters:

How Walmart Became the World’s Largest Retailer:  Learn from the Sales and Marketing Strategies of Walmart

Faasos: Embark on a Flavorful Culinary Journey




Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More